Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5641 to 5655 of 7682 results

  1. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with asymptomatic severe heart valve disease (aortic regurgitation, mitral stenosis, mitral regurgitation or tricuspid regurgitation) and no current indication for intervention?

    Recommendation ID NG208/19 Question Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective

    Research recommendation
    Published
    16 December 2021

  2. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with symptomatic moderate heart valve disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation and tricuspid regurgitation) and no current indication for intervention?

    Recommendation ID NG208/20 Question Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective

    Research recommendation
    Published
    16 December 2021

  3. Monitoring when there is no current need for intervention: What is the most clinically and cost-effective monitoring (type and frequency of test) for adults with asymptomatic mild or moderate heart valve disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation and tricuspid regurgitation) and no current need for intervention?

    Recommendation ID NG208/01 Question Monitoring when there is no current need for intervention: What is the most clinically and cost-effective

    Research recommendation
    Published
    16 December 2021

  4. What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?

    Recommendation ID NG131/4 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate

    Research recommendation
    Published
    7 January 2022

  5. Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration:- What is the most clinically and cost effective route of administration for NSAIDs in the management of acute pain thought to be due to renal or ureteric stones?

    Recommendation ID NG118/5 Question Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration:- What is the most clinically

    Research recommendation
    Published
    7 March 2019

  6. Laboratory tests to diagnose initial and ongoing infection and determine re-infection in the different presentations of Lyme disease in the UK:- What is the most clinically and cost-effective serological antibody-based test, biomarker or other test for diagnosing Lyme disease in the UK at all stages, including re-infection?

    Recommendation ID NG95/5 Question Laboratory tests to diagnose initial and ongoing infection and determine re-infection in the different

    Research recommendation
    Published
    27 November 2018

  7. Monitoring after an intervention: What is the most clinically and cost‑effective timing, nature and frequency of follow up for different types of valve interventions, including repair and replacement with tissue or mechanical valves?

    Recommendation ID NG208/04 Question Monitoring after an intervention: What is the most clinically and cost‑effective timing, nature and

    Research recommendation
    Published
    16 December 2021

  8. Clinical call handlers:- What is the most clinically and cost-effective use of clinical call handlers in a telephone advisory service in terms of i) the ratio of clinical to non-clinical call handlers and ii) point of access to clinical call handlers in a telephone advisory service pathway? [See the evidence review on non-emergency telephone access and call handlers.]

    Recommendation ID NG94/6 Question Clinical call handlers:- What is the most clinically and cost-effective use of clinical call handlers

    Research recommendation
    Published
    15 November 2018

  9. What is the effectivness of statin treatment in older people?

    Recommendation ID NG238//2 Question What is the effectivness of statin treatment in older people? Any explanatory notes(if applicable)

    Research recommendation
    Published
    3 May 2024

  10. What staff training interventions are effective at facilitating personal recovery for people with complex psychosis?

    Recommendation ID NG181/7 Question What staff training interventions are effective at facilitating personal recovery for people with complex

    Research recommendation
    Published
    26 October 2020

  11. Stereotactic ablative radiotherapy compared with surgery: What is the effectiveness and cost effectiveness of stereotactic ablative radiotherapy (SABR) compared with surgery (for example, sublobar, wedge resection, lobectomy) for people with non-small-cell lung cancer (stage I and IIA) in whom surgery is suitable?

    Recommendation ID NG122/2 Question Stereotactic ablative radiotherapy compared with surgery: What is the effectiveness and cost effectiveness

    Research recommendation
    Published
    27 April 2023

  12. Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate the clinical and cost effectiveness of hepatitis B surface antigen (HBsAg) quantitative assays in determining treatment duration in hepatitis B e antigen- (HBeAg) negative disease.

    Recommendation ID CG165/1 Question Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate

    Research recommendation
    Published
    9 June 2015

  13. Stopping preventive medicines:- What is the clinical and cost effectiveness of stopping preventive medicines in people with multimorbidity who may not benefit from continuing them?

    Recommendation ID NG56/3 Question Stopping preventive medicines:- What is the clinical and cost effectiveness of stopping preventive medicines

    Research recommendation
    Published
    18 October 2016

  14. Stopping rules for antiangiogenic treatment for late AMD (wet):- When should anti-vascular endothelial growth factor (VEGF) treatment be suspended or stoppedin people with late AMD (wet)?

    Recommendation ID NG82/3 Question Stopping rules for antiangiogenic treatment for late AMD (wet):- When should anti-vascular endothelial

    Research recommendation
    Published
    13 November 2018

  15. Strategies to slow the progression of age-related macular degeneration (AMD):- What is the effectiveness of antioxidant and zinc supplements on AMD disease progression for people with early AMD at high risk of progression in the context of a randomised controlled trial?

    Recommendation ID NG82/1 Question Strategies to slow the progression of age-related macular degeneration (AMD):- What is the effectiveness

    Research recommendation
    Published
    13 November 2018